The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Cancer Med. 2024 Jan;13(2):e6976. doi: 10.1002/cam4.6976.
International bodies recommend that melanoma risk assessment should be integrated into skin cancer care provision, but evidence to support implementation is lacking.
To explore the acceptability and feasibility of implementing personalised melanoma risk assessment and tailored patient education and skin surveillance within routine clinical care.
This prospective qualitative implementation study was informed by the Theoretical Framework of Acceptability (TFA). Personalised, systematic melanoma risk assessment was implemented in the dermatology clinic at the Melanoma Institute Australia, Sydney, Australia February-May 2021. Pre- and post-implementation observations and semi-structured interviews with patients and staff were conducted (September 2020-March 2021). Observational notes and interview transcript data were analysed thematically using the TFA as a classifying framework.
A total of 37 h of observations were made, and 29 patients and 12 clinic staff were interviewed. We found that the delivery of personalised melanoma risk estimates did not impact on patient flow through the clinic. Dermatologists reported that the personalised risk information enhanced their confidence in assessing patient risk and recommending tailored surveillance schedules. Most patients reported that the risk assessment and tailored information were a beneficial addition to their care. Among patients whose risk deviated from their expectations, some reported feeling worried, confused or mistrust in the risk information, including those at lower risk who were recommended to decrease surveillance frequency.
It is feasible and acceptable to patients and clinic staff to calculate and deliver personalised melanoma risk information and tailored surveillance as part of routine clinical care within dermatology clinics.
国际机构建议将黑色素瘤风险评估纳入皮肤癌护理服务,但缺乏支持实施的证据。
探索在常规临床护理中实施个性化黑色素瘤风险评估以及针对患者的教育和皮肤监测的可接受性和可行性。
本前瞻性定性实施研究以可接受性理论框架(TFA)为指导。2021 年 2 月至 5 月,在澳大利亚悉尼的澳大利亚黑色素瘤研究所的皮肤科诊所实施了个性化、系统性的黑色素瘤风险评估。在实施前后对患者和工作人员进行了观察和半结构化访谈(2020 年 9 月至 2021 年 3 月)。使用 TFA 作为分类框架,对观察记录和访谈转录数据进行主题分析。
共进行了 37 小时的观察,对 29 名患者和 12 名诊所工作人员进行了访谈。我们发现,提供个性化黑色素瘤风险估计并不会影响患者在诊所的就诊流程。皮肤科医生报告称,个性化风险信息增强了他们评估患者风险和建议量身定制监测计划的信心。大多数患者报告说,风险评估和量身定制的信息对他们的护理很有帮助。在风险与预期不符的患者中,一些人表示对风险信息感到担忧、困惑或不信任,包括那些风险较低但被建议减少监测频率的患者。
在皮肤科诊所的常规临床护理中,计算和提供个性化黑色素瘤风险信息以及量身定制的监测对于患者和诊所工作人员来说是可行且可接受的。